Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|July 27, 2002
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHuiling Yang, Christopher E Westland, William E Delaney, et al.
AIDS (London, England)|June 5, 2002
Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind studyRobert T Schooley, Peter Ruane, Robert A Myers, et al.
Antiviral Therapy|March 2, 2017
In vitro selection of resistance to sofosbuvir in HCV replicons of genotype-1 to -6Simin Xu, Brian Doehle, Sonal Rajyaguru, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2016
Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A ProteinEric J Lawitz, Hadas Dvory-Sobol, Brian P Doehle, et al.
Journal of Virology|October 28, 2004
Murine T cells potently restrict human immunodeficiency virus infectionJörg G Baumann, Derya Unutmaz, Michael D Miller, et al.
AIDS (London, England)|December 20, 2011
Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failureJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
AIDS (London, England)|October 18, 2005
A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RTKirsten L White, Nicolas A Margot, John K Ly, et al.
The Journal of Antimicrobial Chemotherapy|October 14, 2017
Identification of novel bifunctional HIV-1 reverse transcriptase inhibitorsMing-Tain Lai, Paul Tawa, Anick Auger, et al.
Journal of Immunological Methods|March 17, 2007
Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assaysBin Su, Renee Hrin, Barrett R Harvey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2016
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based TherapiesChristoph Sarrazin, Vasily Isakov, Evguenia S Svarovskaia, et al.
Pageof 21